Why the study?
Despite the high AF burden in patients presenting for TMVR, no studies had evaluated the impact of AF on in-hospital outcomes in a nationally representative US sample reflecting real practice.
Does the presence of atrial fibrillation worsen in-hospital outcomes in patients undergoing transcatheter mitral valve repair?
Does the presence of atrial fibrillation worsen in-hospital outcomes in patients undergoing transcatheter mitral valve repair?
Answers are grounded in this paper and cite their sources.
Atrial fibrillation is common in patients undergoing TMVR but does not significantly impact in-hospital mortality or complications, though it is associated with higher rates of non-routine discharge.
BACKGROUND: The concomitant presence of atrial fibrillation (AF) in the setting of Transcatheter Mitral Valve Repair (TMVR) represents a clinical challenge. Despite the high AF burden in patients presenting for the TMVR procedure, there are no studies that evaluate the impact of AF on in-hospital outcomes of TMVR in a nationally representative United States sample reflecting real practice. Therefore, we sought to study the outcomes of AF patients undergoing TMVR. METHODS AND RESULTS: The study included 1026 patients from the National Inpatient Sample (NIS) registry. Patients (age ≥18 years) who had undergone TAVR as a primary procedure from 2011 to 2014 were included, using the ICD-9-CM diagnostic codes. We examined patient characteristics and in-hospital outcomes. To account for patient and hospital-level baseline differences, we performed propensity score-matched analysis. The prevalence of AF was approximately 56%. After adjusting for patient-level and hospital-level characteristics, there was no statistical difference regarding in-hospital mortality (odds ratio [OR] 0.72, 95%CI 0.29-1.80, P = 0.487), post-TMVR complications, length of stay (OR 1.15, 95%CI 0.97-1.38, P = 0.111), and cost of hospitalization (OR 1.04, 95%CI 0.94-1.14, P = 0.475) between the group with AF versus without AF. However, patients with AF were more likely to have non-routine hospital discharge (42.94% vs 35.48% P = 0.02). CONCLUSION: AF is a frequently encountered arrhythmia among patients undergoing TMVR with MitraClip. However, TMVR can be performed safely in the vast majority of patients, irrespective of their baseline rhythm.
No takes yet. Share an insight, caveat, or question.
Subahi et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: